Molecular Partners AG (MOLN) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 1 Buy, 3 Hold.
The consensus price target is $13.00, representing an upside of 214% from the current price $4.14.
Analysts estimate Earnings Per Share (EPS) of $-2.28 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.59 vs est $-2.28 (beat +30.1%). 2025: actual $-1.65 vs est $-2.02 (beat +18.3%). Analyst accuracy: 67%.
MOLN Stock — 12-Month Price Forecast
$13.00
▲ +214.01% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Molecular Partners AG, the price target is $13.00.
The average price target represents a +214.01% change from the last price of $4.14.
MOLN Analyst Ratings
Hold
Based on 4 analysts giving stock ratings to Molecular Partners AG in the past 3 months
EPS Estimates — MOLN
67%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$1.59
vs Est –$2.28
▲ 43.1% off
2025
Actual –$1.65
vs Est –$2.02
▲ 22.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — MOLN
83%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.005B
vs Est $0.006B
▼ 17.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
